Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

被引:48
|
作者
Monnier, Vincent M. [1 ,2 ]
Sun, Wanjie [3 ]
Gao, Xiaoyu [3 ]
Sell, David R. [1 ]
Cleary, Patricia A. [3 ]
Lachin, John M. [3 ]
Genuth, Saul [4 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] George Washington Univ, Ctr Biostat, Rockville, MD USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
AGEs; A1c; DCCT/EDIC; Coronary artery calcium; Intima media thickening; Cardiac indices; CARBOXYMETHYL-LYSINE; CROSS-LINKING; END-PRODUCTS; COMPLICATIONS; GLUCOSEPANE; GLYCOXIDATION; CALCIFICATION; INTERVENTIONS; ACCUMULATION; PARTICIPANTS;
D O I
10.1186/s12933-015-0266-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We recently reported strong associations between eight skin collagen AGEs and two solubility markers from skin biopsies obtained at DCCT study closeout and the long-term progression of microvascular disease in EDIC, despite adjustment for mean glycemia. Herein we investigated the hypothesis that some of these AGEs (fluorescence to be reported elsewhere) correlate with long-term subclinical cardiovascular disease (CVD) measurements, i.e. coronary artery calcium score (CAC) at EDIC year 7-9 (n = 187), change of carotid intima-media thickness (IMT) from EDIC year 1 to year 6 and 12 (n = 127), and cardiac MRI outcomes at EDIC year 15-16 (n = 142). Methods: Skin collagen AGE measurements obtained from stored specimens were related to clinical data from the DCCT/EDIC using Spearman correlations and multivariable logistic regression analyses. Results: Spearman correlations showed furosine (early glycation) was associated with future mean CAC (p < 0.05) and CAC > 0 (p = 0.39), but not with CAC score < 100 vs. > 100. Glucosepane and pentosidine crosslinks, methylglyoxal hydroimidazolones (MG-H1) and pepsin solubility (inversely) correlated with IMT change from year 1 to 6(all P < 0.05). Left ventricular (LV) mass (cMRI) correlated with MG-H1, and inversely with pepsin solubility (both p < 0.05), while the ratio LV mass/end diastolic volume correlated with furosine and MG-H1 (both p < 0.05), and highly with CML (p < 0.01). In multivariate analysis only furosine (p = 0.01) was associated with CAC. In contrast IMT was inversely associated with lower collagen pepsin solubility and positively with glucosepane, Conclusions: In type 1 diabetes, multiple AGEs are associated with IMT progression in spite of adjustment for A1c implying a likely participatory role of glycation and AGE mediated crosslinking on matrix accumulation in coronary arteries. This may also apply to functional cardiac MRI outcomes, especially left ventricular mass. In contrast, early glycation measured by furosine, but not AGEs, was associated with CAC score, implying hyperglycemia as a risk factor in calcium deposition perhaps via processes independent of glycation.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study
    Holte, Kristine Bech
    Juel, Niels Gunnar
    Brox, Jens Ivar
    Hanssen, Kristian Folkvord
    Fosmark, Dag Sigurd
    Sell, David R.
    Monnier, Vincent M.
    Berg, Tore Julsrud
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (09) : 1408 - 1414
  • [22] Oxidative and Advanced Glycation End Products Predict Cardiovascular Disease in Type 1 Diabetes
    Beisswenger, Paul J.
    Bebu, Ionut
    Howell, Scott
    Pan, Helen
    Lachin, John M.
    DIABETES, 2017, 66 : A117 - A117
  • [23] Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes
    Y. Yu
    S. R. Thorpe
    A. J. Jenkins
    J. N. Shaw
    M. A. Sochaski
    D. McGee
    C. E. Aston
    T. J. Orchard
    N. Silvers
    Y. G. Peng
    J. A. McKnight
    J. W. Baynes
    T. J. Lyons
    Diabetologia, 2006, 49 : 2488 - 2498
  • [24] Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes
    Yu, Y.
    Thorpe, S. R.
    Jenkins, A. J.
    Shaw, J. N.
    Sochaski, M. A.
    McGee, D.
    Aston, C. E.
    Orchard, T. J.
    Silvers, N.
    Peng, Y. G.
    McKnight, J. A.
    Baynes, J. W.
    Lyons, T. J.
    DIABETOLOGIA, 2006, 49 (10) : 2488 - 2498
  • [25] Advanced glycation endproducts in serum and long term HbA1c are associated with tissue plasminogen activator antigen, a marker of atherosclerosis, in type 1 diabetes
    Larsen, JR
    Kilhovd, BK
    Berg, TJ
    Seljeflot, IB
    Sandvik, L
    Arnesen, H
    Hanssen, KTF
    Dahl-Jorgensen, K
    DIABETES, 2004, 53 : A181 - A181
  • [26] Glycation products in skin collagen predict future progression of retinopathy over ten years in type 1 diabetes
    Genuth, S
    Monnier, V
    Sun, W
    DIABETES, 2005, 54 : A226 - A226
  • [27] Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes
    C. S. Arun
    R. Taylor
    Diabetologia, 2008, 51 : 1041 - 1045
  • [28] Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes
    Arun, C. S.
    Taylor, R.
    DIABETOLOGIA, 2008, 51 (06) : 1041 - 1045
  • [29] Sub-clinical vascular disease in type 2 diabetic subjects: Relationship with chronic complications of diabetes and the presence of cardiovascular disease risk factors
    Mostaza, Jose
    Suarez, Carmen
    Manzano, Luis
    Cairols, Marc
    Lopez-Fernandez, Fernando
    Aguilar, Isabel
    Lois, Fernando Diz
    Sampedro, Juan L.
    Sanchez-Huelva, Herminia
    Sanchez-Zamorano, Miguel A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (04) : 255 - 260
  • [30] Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes
    Adeshara, Krishna
    Gordin, Daniel
    Antikainen, Anni A.
    Harjutsalo, Valma
    Sandholm, Niina
    Lehto, Markku J.
    Groop, Per-Henrik
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)